ACTIVE SUBSTANCE / INN

INTERFERON BETA-1B

Brand name(s): Betaferon, BETASERON, Extavia
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
AUTHORISED
BLA103471
Multiple Sclerosis
ACTIVE SUBSTANCE
Interferon Beta-1B
REGULATORS
FDA · EMA
SPONSORS / MAH
BAYER HEALTHCARE PHARMS, Bayer AG , Novartis Europharm Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BETASERONBLA103471BAYER HEALTHCARE PHARMSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ExtaviaNovartis Europharm LimitedWithdrawn20/05/2008Multiple Sclerosis
BetaferonBayer AG Authorised30/11/1995Multiple Sclerosis

FULL INTELLIGENCE ON INTERFERON BETA-1B

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →